These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease. Sauvageau VM, Roy JP, Langlois M, Macoir J. Clin Linguist Phon; 2015 Jun; 29(6):424-40. PubMed ID: 25688915 [Abstract] [Full Text] [Related]
3. Changes to articulation following LSVT(R) and traditional dysarthria therapy in non-progressive dysarthria. Wenke RJ, Cornwell P, Theodoros DG. Int J Speech Lang Pathol; 2010 Jun; 12(3):203-20. PubMed ID: 20433339 [Abstract] [Full Text] [Related]
7. Formant centralization ratio: a proposal for a new acoustic measure of dysarthric speech. Sapir S, Ramig LO, Spielman JL, Fox C. J Speech Lang Hear Res; 2010 Feb; 53(1):114-25. PubMed ID: 19948755 [Abstract] [Full Text] [Related]
13. Characteristics of the lax vowel space in dysarthria. Tjaden K, Rivera D, Wilding G, Turner GS. J Speech Lang Hear Res; 2005 Jun; 48(3):554-66. PubMed ID: 16197272 [Abstract] [Full Text] [Related]
14. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment. Ramig LO, Fox C, Sapir S. Semin Speech Lang; 2004 May; 25(2):169-80. PubMed ID: 15118943 [Abstract] [Full Text] [Related]
15. Effect of intensive voice treatment on tone-language speakers with Parkinson's disease. Whitehill TL, Wong LL. Clin Linguist Phon; 2007 May; 21(11-12):919-25. PubMed ID: 17972188 [Abstract] [Full Text] [Related]
16. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study. Sapir S, Spielman J, Ramig LO, Hinds SL, Countryman S, Fox C, Story B. Am J Speech Lang Pathol; 2003 Nov; 12(4):387-99. PubMed ID: 14658991 [Abstract] [Full Text] [Related]
17. [Intrinsic and co-intrinsic vowel characteristics in cerebellar and parkinsonian dysarthrias]. Baudelle E, Vaissière J, Renard JL, Roubeau B, Chevrie-Müller C. Folia Phoniatr Logop; 2003 Nov; 55(3):137-46. PubMed ID: 12771465 [Abstract] [Full Text] [Related]
18. Intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria. Fox CM, Boliek CA. J Speech Lang Hear Res; 2012 Jun; 55(3):930-45. PubMed ID: 22232407 [Abstract] [Full Text] [Related]
19. Home-based speech treatment for Parkinson's disease delivered remotely: a case report. Constantinescu GA, Theodoros DG, Russell TG, Ward EC, Wilson SJ, Wootton R. J Telemed Telecare; 2010 Jun; 16(2):100-4. PubMed ID: 20008051 [Abstract] [Full Text] [Related]
20. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease. Baumann A, Nebel A, Granert O, Giehl K, Wolff S, Schmidt W, Baasch C, Schmidt G, Witt K, Deuschl G, Hartwigsen G, Zeuner KE, van Eimeren T. Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176 [Abstract] [Full Text] [Related] Page: [Next] [New Search]